Title: Evidence-Based Clinical Practice Guideline for THE SCREENING AND PREVENTION OF TYPE 2 DIABETES IN ADOLESCENTS
Edition: Adapted
Classification: Standard guideline
Field: Comprehensive guideline
Countries and regions: Egypt
Guidelines users: -Primary health care physicians at Ministry of Health (MOH). -General pediatricians and school physicians. -Family medicine physicians.
Evidence classification method: The description of the methodology for the production of this adapted CPG can be fulfilled by utilizing the ‘Adapted ADAPTE’ method. This CPG formal adaptation method includes three phases (setup, adaptation, and finalization), nine modules, and 24 steps with modifications in the steps and tools to suit the local general healthcare setting in Egypt. Overall, the steps of CPG adaptation includes the selection of the high-priority health topic, formulation of the CPG adaptation working group, identification of health questions using the PIPOH model, searching and selecting the source original CPGs with clear inclusion and exclusion criteria, quality assessment of included source CPGs by using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument, assessment of the currency of the selected source CPGs, drafting of the adapted CPG, external review and consultation process, finalization of the adapted CPG with a set of implementation tools, declaration of conflicts of interests, and finally a plan for review and update. For further details on the specific modifications in steps and tools, refer to the article https://doi.org/10.1111/jep.12479].
Development unit: Egyptian Pediatric Guideline Committee
Registration time: 2022-12-27
Registration number: PREPARE-2022CN813
Purpose of the guideline: 1) Screening for early detection of prediabetes allowing the opportunity to prevent or delay progression to type 2 diabetes and its comorbidities. 2) Early detection of type 2 diabetes in high-risk groups, to prevent or delay serious diabetes complications during adolescence and early adulthood. 3) Screening for early diagnosis of comorbidities or complications in adolescents with prediabetes and type 2 diabetes to prevent serious disabilities during adolescence and early adulthood.